Biodexa Pharmaceuticals Toekomstige groei
Future criteriumcontroles 0/6
Biodexa Pharmaceuticals's revenue is forecast to decline at 70.6% per annum.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Biotechs winstgroei | 27.1% |
Inkomstengroei | -70.6% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 04 Jun 2024 |
Recente toekomstige groei-updates
Geen updates
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 0 | N/A | N/A | N/A | 1 |
12/31/2025 | 0 | N/A | N/A | N/A | 1 |
12/31/2024 | 0 | N/A | N/A | N/A | 1 |
6/30/2024 | 0 | -7 | -9 | -8 | N/A |
3/31/2024 | 0 | -7 | -8 | -7 | N/A |
12/31/2023 | 0 | -7 | -7 | -7 | N/A |
9/30/2023 | 0 | -8 | -7 | -7 | N/A |
6/30/2023 | 1 | -8 | -7 | -7 | N/A |
3/31/2023 | 1 | -8 | -7 | -7 | N/A |
12/31/2022 | 1 | -8 | -7 | -7 | N/A |
9/30/2022 | 1 | -7 | -7 | -7 | N/A |
6/30/2022 | 1 | -5 | -7 | -6 | N/A |
3/31/2022 | 1 | -5 | -6 | -6 | N/A |
12/31/2021 | 1 | -5 | -6 | -6 | N/A |
9/30/2021 | 1 | -7 | -6 | -6 | N/A |
6/30/2021 | 1 | -8 | -6 | -5 | N/A |
3/31/2021 | 0 | -15 | -8 | -7 | N/A |
12/31/2020 | 0 | -22 | -10 | -9 | N/A |
6/30/2020 | 0 | -22 | -9 | -9 | N/A |
3/31/2020 | 1 | -16 | -8 | -8 | N/A |
12/31/2019 | 1 | -9 | -7 | -6 | N/A |
6/30/2019 | 2 | -9 | -10 | -10 | N/A |
3/31/2019 | 2 | -10 | -12 | -12 | N/A |
12/31/2018 | 2 | -10 | -14 | -13 | N/A |
6/30/2018 | 1 | -11 | -11 | -11 | N/A |
3/31/2018 | 1 | -11 | N/A | -12 | N/A |
12/31/2017 | 1 | -12 | N/A | -13 | N/A |
9/30/2017 | -3 | -1 | N/A | -14 | N/A |
6/30/2017 | 4 | -18 | N/A | -15 | N/A |
3/31/2017 | 6 | -19 | N/A | -14 | N/A |
12/31/2016 | 1 | -6 | N/A | -13 | N/A |
9/30/2016 | 5 | -17 | N/A | -14 | N/A |
6/30/2016 | 4 | -13 | N/A | -15 | N/A |
3/31/2016 | 3 | -12 | N/A | -14 | N/A |
12/31/2015 | 1 | -10 | N/A | -12 | N/A |
9/30/2015 | 1 | -10 | N/A | -11 | N/A |
6/30/2015 | 0 | -11 | N/A | -9 | N/A |
3/31/2015 | 0 | -10 | N/A | -7 | N/A |
12/31/2014 | 0 | -9 | N/A | -5 | N/A |
9/30/2014 | 0 | -7 | N/A | -5 | N/A |
6/30/2014 | 0 | -5 | N/A | -5 | N/A |
3/31/2014 | 0 | -4 | N/A | -5 | N/A |
12/31/2013 | 0 | -4 | N/A | -4 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if BDRX's forecast earnings growth is above the savings rate (2.5%).
Winst versus markt: Insufficient data to determine if BDRX's earnings are forecast to grow faster than the US market
Hoge groeiwinsten: Insufficient data to determine if BDRX's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: BDRX's revenue is expected to decline over the next 3 years (-70.6% per year).
Hoge groei-inkomsten: BDRX's revenue is forecast to decline over the next 3 years (-70.6% per year).
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if BDRX's Return on Equity is forecast to be high in 3 years time